Greg Elgar: How does clinical whole genome sequencing work in the real world?

"We're taking the native DNA molecule that's actually from the
cell and we're reading the sequence of that molecule. That comes
with some tremendous, enormous benefits, but it also comes with
it some huge challenges."


On today's episode of The G Word, we are joined by Parker Moss,
our Chief Commercial Officer at Genomics England, and Greg Elgar,
the Director of Sequencing Economic England.


They discuss techniques such as preparation ahead of sequencing
itself and the logistics to get blood and tissue from humans into
the sequencing lab in Cambridge. They also delve into the science
of how sequencing itself works, what is needed for accurate
sequencing and highlight and debate the implications of genomics,
as well as, how it comes into the mainstream of health care and
society.